Advanced search - COVID-19 Research Repository - COVID-19 - Infectious diseases - Health protection - Population health - Public Health Scotland

Filter by publication date

From

Month Year

Test

To

Month Year

Test

Apply date filter

Showing 19 results

Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19

Author

Houchen-Wolloff, Linzy; Poinasamy, Krisnah; Holmes, Kate; Tarpey, Maryrose; Hastie, Claire E.; Raihani, Kelly; Rogers, Natalie; Smith, Nikki; Adams, Dawn; Burgess, Paul and 31 others

Source

Thorax

Type

Journal article

Published

30 March 2022
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19

Author

Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) Covid BioResource Collaboration; Wang, Jun; Kotagiri, Prasanti; Lyons, Paul A.; Al-Lamki, Rafia; Mescia, Federica; Bergamaschi, Laura; Turner, Lorinda; Morgan, Michael D.; Calero-Nieto, Fernando J. and 25 others

Source

iScience

Type

Journal article

Published

22 February 2022
The impact of hypoxia on B cells in COVID-19

Author

Kotagiri, Prasanti; Mescia, Federica; Hanson, Aimee L.; Turner, Lorinda; Bergamaschi, Laura; Peñalver, Ana; Richoz, Nathan; Moore, Stephen D; Ortmann, Brian M; Dunmore, Benjamin J. and 13 others

Source

eBioMedicine

Type

Journal article

Published

18 February 2022
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

Author

Evans, Rachael A.; McAuley, Hamish; Harrison, Ewen M.; Shikotra, Aarti; Singapuri, Amisha; Sereno, Marco; Elneima, Omer; Docherty, Annemarie B.; Lone, Nazir I.; Leavy, Olivia C. and 43 others

Source

The Lancet Respiratory Medicine

Type

Journal article

Published

07 October 2021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Author

Flaxman, Amy; Marchevsky, Natalie G.; Jenkin, Daniel; Aboagye, Jeremy; Aley, Parvinder K.; Angus, Brian; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Bittaye, Mustapha; Cappuccini, Federica and 177 others

Source

Lancet

Type

Journal article

Published

11 September 2021
Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: a self-controlled case series analysis of a nation-wide cohort

Author

Ho, Frederick K.; Man, Kenneth K.S.; Toshner, Mark R.; Church, Colin; Celis-Morales, Carlos A.; Wong, Ian C.K.; Berry, Colin; Sattar, Naveed; Pell, Jill P.

Source

Mayo Clinic Proceedings

Type

Journal article

Published

16 July 2021
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease

Author

Bergamaschi, Laura; Mescia, Federica; Turner, Lorinda; Hanson, Aimee L.; Kotagiri, Prasanti; Dunmore, Benjamin J.; Ruffieux, Hélène; Sa, Aloka De; Huhn, Oisín; Morgan, Michael D. and 27 others

Source

Immunity

Type

Journal article

Published

16 May 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Author

Emary, Katherine R.W.; Golubchik, Tanya; Aley, Parvinder K.; Ariani, Cristina V.; Angus, Brian; Bibi, Sagida; Blane, Beth; Bonsall, David; Cicconi, Paola; Charlton, Sue and 54 others

Source

The Lancet

Type

Journal article

Published

10 April 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Author

Voysey, Merryn; Clemens, Sue Ann Costa; Madhi, Shabir A.; Weckx, Lily Y.; Folegatti, Pedro M.; Aley, Parvinder K.; Angus, Brian; Baillie, Vicky L.; Barnabas, Shaun L.; Bhorat, Qasim E. and 70 others

Source

The Lancet

Type

Journal article

Published

06 March 2021

There are no more search results.